Home > Healthcare > Biotechnology > Biopharma > Monoclonal Antibodies Market
Monoclonal Antibodies Market Share
- Report ID: GMI5065
- Published Date: Jul 2023
- Report Format: PDF
Monoclonal Antibodies Market Share
Some of notable key players operating in the monoclonal antibodies market including
- AbbVie Inc.
- F. Hoffmann-La Roche
- Amgen Inc.
- Bristol Myers Squibb
- Johnson & Johnson
- Merck & Co., Inc.
- Regeneron Pharmaceuticals Inc.
- AstraZeneca
- Eli Lilly and Company
- GlaxoSmithKline plc
- Takeda Pharmaceutical Company Limited
- Novartis AG
Frequently Asked Questions (FAQ) :
Global market size for monoclonal antibodies surpassed USD 186.6 billion in 2022 and is estimated to exceed USD 609 billion by 2032 driven by the increasing prevalence of chronic and infectious diseases along with growing number of R&D activities
Fully human monoclonal antibodies industry held 50.8% revenue share in 2022 and is estimated to witness high demand through 2032 attributed to the increasing number of product approvals and drug launches of fully human monoclonal antibodies.
North America recorded more than 48.8% share of the market in 2022 and is poised to record substantial growth between 2023 and 2032 attributed to the strong presence of key business players and the rising number of product approvals.
Some of the major companies operating in the industry are AbbVie Inc., F. Hoffmann-La Roche, Bristol Myers Squibb, Amgen Inc., Bristol Myers Squibb, Johnson & Johnson, Merck & Co., Inc., Regeneron Pharmaceuticals Inc., AstraZeneca, Eli Lilly and Company, and GlaxoSmithKline plc,
Monoclonal Antibodies Market Scope
×
Get a free sample of
Monoclonal Antibodies Market
Inquiry Before Buying
Get special pricing options on this report
Request Sectional Data
Over 70% of our clients customize reports to fit their needs. Please tell us how you would like to customize yours
below